News | August 28, 2007

ESC Releases New Cardiac Pacing Guidelines

August 29, 2007 - The European Society of Cardiology has released new ESC Guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy. These new guidelines cover two main areas: The permanent pacing in bradyarrhythmias, syncope and other specific conditions like hypertrophic obstructive cardiomyopathy and ventricular resynchronization as an adjunct therapy in patients with heart failure. The guidelines also cover complex devices like pacemakers and cardiac synchronizers.

“Thanks to important developments in technology and advances in the essential knowledge which we now have concerning the physiology of the paced beat, patients with sinus node dysfunction and atrioventricular conduction system defects can now be given high quality therapy,” said Professor Panos Vardas, chairman of the ESC Guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy. “These and other developments over the last few years have advanced electrical stimulation further into the realm of ventricular resynchronization as an adjunctive therapy for patients with drug-refractory heart failure and ventricular conduction delay.”

The Guidelines will be published in the European Heart Journal (European Heart Journal 2007 doi: 10.1093/eurheart/ehm305) and are available online.

For more information: www.escardio.org


Related Content

News | Pacemakers

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...

Home March 26, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world ...

Home March 15, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first ...

Home March 15, 2024
Home
News | Pacemakers

January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité ...

Home January 05, 2024
Home
News | Pacemakers

August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...

Home August 21, 2023
Home
News | Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

Home July 06, 2023
Home
News | Pacemakers

July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...

Home July 05, 2023
Home
News | Pacemakers

June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only ...

Home June 01, 2023
Home
News | Pacemakers

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
Home
News | Pacemakers

May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...

Home May 12, 2023
Home
Subscribe Now